drugset / Trial / NCT07674966

An Investigation of Topical Ophthalmic Low-Dose Atropine on Pupil Size and Accommodation

NCT07674966

Phase 1 Completed 24 enrolled University of California, Berkeley
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of this clinical study is to learn about the short-term physiological effects of low-dose atropine in healthy volunteers. The study seeks to examine three questions related to low-dose topically applied ophthalmic atropine: 1. Does applying two drops of 0.01% atropine sulfate solution cause the same clinical effects as one drop of 0.02% atropine? 2. How quickly do the pupil responses and accommodative amplitudes recover following a dose of 0.01% atropine, 0.02% atropine, and 0.05% atropine? 3. Does applying a single drop of 0.02% atropine sulfate solution cause the same clinical effects in participants with light vs. dark iris colors? Participants will have their pupil size and accommodative status measured at appropriate intervals to answer the questions above.

Timeline

Start
2022-03-16
Primary completion
2022-10-09
Completion
2022-10-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.01 % Topical
Subject Atropine Other / unclassified 0.02 % Topical
Subject Atropine Other / unclassified 0.05 % Topical

Indications